Literature DB >> 1505601

Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failure.

A D Flapan1, T R Shaw, C R Edwards, M Rademaker, E Davies, B C Williams.   

Abstract

We have given a series of incremental intravenous injections of captopril to ten patients with chronic cardiac failure. Small doses of captopril produced significant changes in pulmonary artery end-diastolic pressure and right atrial pressure, up to a total cumulative dose of captopril of 2.5 mg, after which further injections had no significant effect. There were large changes in systemic vascular resistance and blood pressure up to a cumulative dose of captopril of 5.0 mg, after which the injection of larger doses caused no further significant changes. Small doses of intravenous captopril produced large increases in plasma renin activity and plasma angiotensin I concentrations up to a total cumulative dose of captopril of 1.25 mg, after which there were no significant further changes in either plasma renin activity or plasma angiotensin I concentration. However the plasma concentration of angiotensin II fell more slowly, no further change being recorded after a total cumulative dose of captopril of 10 mg. These results suggest that plasma renin activity is not the only determinant of plasma angiotensin II concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505601     DOI: 10.1007/bf02280745

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  41 in total

1.  Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model.

Authors:  R J Francis; A N Brown; L Kler; T Fasanella d'Amore; J Nussberger; B Waeber; H R Brunner
Journal:  J Cardiovasc Pharmacol       Date:  1987-01       Impact factor: 3.105

2.  Pharmacokinetics of an ACE inhibitor, S-9780, in man: evidence of tissue binding.

Authors:  K R Lees; A W Kelman; J L Reid; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1989-10

3.  Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats.

Authors:  T Unger; D Ganten; R E Lang; B A Schölkens
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jan-Feb       Impact factor: 3.105

4.  Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.

Authors:  D P Faxon; M A Creager; J L Halperin; H Gavras; J D Coffman; T J Ryan
Journal:  Circulation       Date:  1980-05       Impact factor: 29.690

5.  Angiotensin I, II, and III in sheep. A model of angiotensin production and metabolism.

Authors:  D T Fei; B A Scoggins; G W Tregear; J P Coghlan
Journal:  Hypertension       Date:  1981 Nov-Dec       Impact factor: 10.190

6.  Comparison of captopril and enalapril in patients with severe chronic heart failure.

Authors:  M Packer; W H Lee; M Yushak; N Medina
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

7.  Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.

Authors:  J Cleland; P Semple; P Hodsman; S Ball; I Ford; H Dargie
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

8.  Angiotensin converting enzyme inhibition in patients with congestive heart failure.

Authors:  H Gavras; D P Faxon; J Berkoben; H R Brunner; T J Ryan
Journal:  Circulation       Date:  1978-11       Impact factor: 29.690

9.  Discrepancy between first-dose converting enzyme inhibition at rest and subsequent inhibition during exercise in chronic heart failure.

Authors:  P C Kirlin; C Dansby; C K Laird; P W Willis
Journal:  Clin Pharmacol Ther       Date:  1988-06       Impact factor: 6.875

10.  Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.

Authors:  C I Johnston; B Jackson; B McGrath; G Matthews; L Arnolda
Journal:  J Hypertens Suppl       Date:  1983-10
View more
  1 in total

1.  Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study.

Authors:  B Beermann; O Nyquist; C Höglund; K A Jacobsson; U Näslund; M Jensen-Urstad
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.